Full-dose blood thinners reduce need for organ support in non-ICU hospital patients

Jan 22, 2021 - 02:34 PM
COVID19 Web Sized

Full-dose blood thinner treatments can reduce the need for vital organ support such as ventilation in moderately ill patients hospitalized for COVID-19, according to interim results from a clinical trial announced today by the National Institutes of Health.

The patients were not in intensive care or on organ support when enrolled in the study, which found full doses of heparin were safe and better at reducing the need for ventilation or other organ support than the lower doses normally given to prevent blood clots in hospitalized patients.

The findings complement an earlier study that found routine use of full-dose blood thinners does not benefit COVID-19 patients when started in the intensive care unit. The investigators are working to make the full study results available as soon as possible, NIH said.

Related News Articles

Headline
CDC report finds COVID-19 vaccine for children reduced chances of ED, urgent care visits
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…
Headline
AHA responds to FDA request for information on AI-enabled medical devices
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
Permanent recall issued for Baxter ventilation system
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…
Headline
CDC data shows rise in flu, COVID-19 cases across states 
Flu cases are growing or likely growing in 39 states, according to the latest Centers for Disease Control and Prevention data from Nov. 11. COVID-19…
Headline
Recall issued for mislabeled potassium chloride
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled…
Headline
Study finds flu, COVID-19 infection temporarily raises risk of heart attack, stroke 
A study published Oct. 30 by the American Heart Association found that people have an elevated risk of heart attack and stroke following flu and COVID-19…